newsflow27 May 2020 13:36
I attribute recent rises to two things really - rerating (like rest of market pretty much) from the initial covid shocks and secondly the expectation (company having confirmed on track) of finance.
News of delay to finance is likely to send us down, how low, don't know. Not saying that is coming, but if.
In the meantime we probably haven't had enough crystal clear news (Cannacord buying aside) to give us that nudge up beyond pre-covid territory.
Will that change tomorrow? If there is no RNS I can't see material new facts being discussed in the evening call - perhaps a reiteration that we are on track, maybe confirmation of timescales but surely new information can not be released then. Will we get an RNS? Don't know, I'm probably not expecting one, but it will be a pleasant surprise if we do.
I'm sure a lot has gone on behind closed doors but until we know more about what, it seems unlikely we will re-rate. Maybe in the case of Horizonte the info is just not 'leaky' enough as it appears to be sometimes on other stocks :)
Lets see what JM says tomorrow and take it from there! I doubt we would fall below 3p unless there is a chunky delay because I think sub 3p territory represents covid panic levels. Whilst S America may be seeing the worst of the pandemic now the rest of the world is starting to move into next phase. Long term economic detrimental impacts of course but initial panic over. World still needs nickel etc. prices haven't collapsed.